LifeScan, Inc. 501k Application For FDA Clearance For OneTouch Verio Flex Wireless Integration

In this undated application to the U.S. Food and Drug Administration (FDA), LifeScan, Inc., presented data to support its request for device marketing clearance to wirelessly transmit blood glucose data collected by its OneTouch Verio Flex to the BlueStar clinically validated diabetes management platform. LifeScan will integrate with the BlueStar platform to create a digital health solution via Bluetooth capability for people living with Type 2 diabetes. LifeScan announced on December 14, 2016 that the FDA had approved the request . . .